Dr. Melissa Bourgeois from Merck Animal Health joins us to talk about the exciting new launch of a monoclonal antibody gilvetmab that will allow veterinary oncologists to use the checkpoint inhibitor to recognize and fight cancer cells.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More